Dr. Matsangou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 N Saint Clair St
Ste 850
Chicago, IL 60611Phone+1 312-695-6182
Education & Training
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2008 - 2011
- Carilion Clinic-Virginia Tech Carilion School of MedicineResidency, Internal Medicine, 2005 - 2008
- Warwick Medical School Class of 2000
Certifications & Licensure
- IL State Medical License 2011 - 2023
- NC State Medical License 2012 - 2015
Publications & Presentations
PubMed
- Population Pharmacokinetic Modeling and Exposure-Response Analysis for the Antibody-Drug Conjugate Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Carc...Peiying Zuo, Peter Bonate, Amit Garg, Maria Matsangou, Mei Tang
Clinical Pharmacology and Therapeutics. 2024-11-01 - 1 citationsGlobal prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.Kohei Shitara, Rui-Hua Xu, Jaffer A Ajani, Diarmuid Moran, Abraham Guerrero
Gastric Cancer. 2024-09-01 - Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy.Jonathan E Rosenberg, Ronac Mamtani, Guru P Sonpavde, Yohann Loriot, Ignacio Duran
European Urology. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: